Nel ASA Races the Clock: €11M EU Tranche Buys Time as Old Production Lines Risk Impairment

Norwegian hydrogen firm Nel ASA receives first €11M EU Innovation Fund tranche, but a 73% order collapse and potential asset impairment cloud H1 results due July 15.

Nel ASA enters a critical stretch where a fresh injection of Brussels cash must offset a plunge in new orders and an overhang of mothballed factory equipment. The Norwegian hydrogen specialist expects to collect the first €11 million instalment from the European Union’s Innovation Fund during the current quarter, a lifeline that shores up a liquidity runway running only through the end of 2026. But that same technology upgrade is forcing a painful book-value review of its legacy production lines, threatening to weigh on the half-year numbers due July 15.

The stock closed Friday at €0.30, nudging the year’s high after a 56% surge since January. That rally has widened the gap with the 200-day moving average to 48%. On a monthly basis, the shares have climbed nearly 42%, pushing the market capitalisation close to 6 billion Norwegian kroner. Yet the operating picture tells a far more sobering story: first-quarter order intake collapsed 73%, dragging the total backlog down to 1.1 billion kroner.

Management has already sliced a quarter of the workforce to stem the bleeding, and the net loss narrowed as personnel costs fell. But the balance sheet still faces a specific threat from the company’s decision to idle its older production lines in favour of a new pressurised alkaline platform at the Herøya facility. Nel is now assessing the carrying value of those silent assets, and an impairment charge could mar the first-half results due out in mid-July.

The €11 million tranche represents the first slice of a total EU commitment of up to €135 million. The capital is earmarked for the Herøya expansion, where Nel aims to lift annual production capacity from one gigawatt to four gigawatts. The new technology promises to cut customers’ capital expenditure by as much as 60%, making it a potential game-changer for hydrogen project economics. The global project pipeline is already providing some tailwinds: Oman recently tendered a hydrogen power plant of up to one gigawatt, highlighting the scale of opportunities.

Professional investors, however, remain unconvinced by the stock’s momentum. The average analyst price target stands well below current levels, implying a downside risk of roughly 34%. Individual forecasts range from 1.00 kroner to 4.20 kroner. Berenberg recently trimmed its target to 2.30 kroner, while Citigroup cut to 2.40 kroner; neither bank carries a buy rating. The gap between the share price and the consensus view highlights the tension between a rally fuelled by a long-term hydrogen narrative and a near-term earnings profile that remains negative on a per-share basis.

Traders will look for technical clues in the coming days. Friday’s high serves as immediate resistance; a break above that opens the path to a test of the annual peak. Downside protection sits at Friday’s low. For Nel, every order announcement for the new platform will be scanned as evidence of market acceptance, no matter how small. The next major milestone comes on July 15, when the true cost of the technology transition – including any write-downs – will be laid bare.